Optical Tissue Analysis for Resection Margin Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for intra-operative inspection of resection margins during tumor surgery are laborious and time-consuming, often resulting in inadequate resection margins due to insufficient guidance for surgeons, especially in complex anatomical areas like the oral cavity, where visual inspection and palpation are insufficient to ensure complete tumor removal.

Innovation Solution

A method that measures spatial variance of analyte concentrations in tissue samples using optical techniques like Raman spectroscopy, correlating the variance with the presence of tumor tissue to accurately determine resection margins, providing real-time feedback on the depth and extent of tumor tissue to ensure adequate resection margins are achieved.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If frozen section procedure is used for intraoperative assessment of resection margins, then histological evaluation can be performed, but the procedure is laborious and time consuming leading to limited sample inspection and sampling error

Engineering Contradiction:
Improvehistological evaluation accuracyVSAvoidprocedure time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical frozen section procedure with optical spectroscopy (Raman, fluorescence, or absorbance spectroscopy) to analyze tissue samples. The optical probe delivers light to the tissue and detects spectral signatures that indicate tumor presence, eliminating the need for physical tissue sectioning, freezing, and microscopic examination by pathologists. This substitution maintains measurement precision while dramatically reducing procedure time.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates an optical copy or spectral fingerprint of the tissue's molecular composition without physically altering or sectioning the tissue. By analyzing the spectral signature of analytes (such as water, lipids, proteins) in the tissue, the system generates information equivalent to histological evaluation but without the time-consuming frozen section process. This allows rapid assessment of resection margins while preserving the original tissue structure.

Inventive Principle:
Principle #26Copying

2Ease of operation

If visual inspection and palpation are used by surgeon, then the procedure is simple and quick, but it is insufficient to warrant adequate resections in complex anatomical areas

Engineering Contradiction:
Improvesurgical simplicityVSAvoidresection margin accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent replaces visual inspection and palpation with optical spectroscopy that provides molecular-level information about tissue composition. The optical probe detects spectral signatures characteristic of tumor tissue versus normal tissue, giving the surgeon precise real-time feedback on resection margins without adding mechanical complexity to the surgical procedure. This maintains ease of operation while dramatically improving measurement precision.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an optical intermediary (the spectroscopy-based detection system) that translates molecular composition into detectable spectral signals. This intermediary provides the surgeon with objective molecular information about tissue identity, bridging the gap between simple visual inspection and complex histological analysis. The system acts as a real-time molecular guide without requiring the surgeon to perform complex procedures.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If multiple measurements are taken at closely spaced locations to improve accuracy, then measurement accuracy as a function of depth improves, but the distance between measurements must be large enough to sample sufficient region

Engineering Contradiction:
Improvedepth measurement accuracyVSAvoidsampling region size
Core Design Contradiction:
Measurement precisionVSArea of stationary object

Solution Approach 1:

The patent addresses the spatial sampling challenge by measuring at multiple depths along the same tissue location rather than requiring large lateral spacing between measurements. The optical probe can selectively focus at different depths within the tissue, obtaining depth-resolved spectral information from the same spatial position. This dimensional approach to sampling allows accurate depth measurement while minimizing the area of tissue required for analysis.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Data Source

PatentEP3405095B1Tissue sample analysis
Publication Date: 2023.12.20 ERASMUS UNIV MEDICAL CENT ROTTERDAM ERASMUS MC
  • EP3405095B1 patent drawingFigure 1A~1B
  • EP3405095B1 patent drawingFigure 2A~2B
  • EP3405095B1 patent drawingFigure 3A~3B

AI summary

Method and instrument for analysing a tissue sample (S). Localized concentrations of an analyte (C) are measured at a plurality of spaced apart locations (dX,dZ) around a controlled depth (Z). Spatial variance (Cv) of the analyte (C) is calculated based on the measured analyte concentrations. The procedure is repeated while varying the controlled depth (Z) to obtain the spatial variance (Cv) as a function of depth (Z). Tissue at a particular depth may be evaluated as tumour tissue (T) when the spatial variance (Cv) is below the threshold. For example, a section distance (R) is calculated between the tissue surface (A) and a depth (Z) where the measured spatial variance (Cv) crosses a predetermined threshold variance (Tv). Feedback can be provided based on a comparison between a calculated section distance (R) and a pre-set minimum section margin (M).